Clinical review: Growth hormone and cardiovascular risk factors

被引：109

作者：

Gola, M ^{[1
]}

Bonadonna, S ^{[1
]}

Doga, M ^{[1
]}

Giustina, A ^{[1
]}

机构：

[1] Univ Brescia, Dept Internal Med, Endocrine Sect, I-25125 Brescia, Italy

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2005年 / 90卷 / 03期

关键词：

D O I：

10.1210/jc.2004-0545

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this article is to review the lessons on the relationship between GH and the principal metabolic cardiovascular risk factors that we learned from studies of GH deficiency (GHD) in the adult. The lesson that "organic" GHD has taught us is that primary impairment in the GH/IGF-I axismay lead to a high-risk cardiovascular profile that is partially reversible during GH replacement. Waiting for the definitive demonstration that GH substitution may reduce cardiovascular mortality in these patients, we find that data so far reported are encouraging and indicate in the beneficial cardiovascular effects of GH one of the major factors supporting this type of treatment in hypopituitary GHD adults. Moreover, enough evidence from GHD studies has been produced to suggest a physiological role for the GH/IGF-I axis in the control and regulation of several metabolic cardiovascular risk factors.

引用

页码：1864 / 1870

页数：7

共 80 条

[1] Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities [J].

Abdu, TAM ;

Neary, R ;

Elhadd, TA ;

Akber, M ;

Clayton, RN .

CLINICAL ENDOCRINOLOGY, 2001, 55 (02) :209-216

[2] Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy [J].

AlShoumer, KAS ;

Cox, KH ;

Hughes, CL ;

Richmond, W ;

Johnston, DG .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2653-2659

[3] BODY-COMPOSITION, BONE METABOLISM, AND HEART STRUCTURE AND FUNCTION IN GROWTH-HORMONE (GH)DEFICIENT ADULTS BEFORE AND AFTER GH REPLACEMENT THERAPY AT LOW-DOSES [J].

AMATO, G ;

CARELLA, C ;

FAZIO, S ;

LAMONTAGNA, G ;

CITTADINI, A ;

SABATINI, D ;

MARCIANOMONE, C ;

SACCA, L ;

BELLASTELLA, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1671-1676

[4] Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment [J].

Attanasio, AF ;

Lamberts, SWJ ;

Matranga, AMC ;

Birkett, MA ;

Bates, PC ;

Valk, NK ;

Hilsted, J ;

Bengtsson, BA ;

Strasburger, CJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :82-88

[5] The effect of hypopituitarism on life expectancy [J].

Bates, AS ;

VantHoff, W ;

Jones, PJ ;

Clayton, RN .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1169-1172

[6] Reduced longevity in untreated patients with isolated growth hormone deficiency [J].

Besson, A ;

Salemi, S ;

Gallati, S ;

Jenal, A ;

Horn, R ;

Mullis, PS ;

Mullis, PE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3664-3667

[7] UNIQUE EFFICIENCY OF METHIONINE METABOLISM IN PREMENOPAUSAL WOMEN MAY PROTECT AGAINST VASCULAR-DISEASE IN THE REPRODUCTIVE YEARS [J].

BOERS, GH ;

SMALS, AG ;

TRIJBELS, FJ ;

LEERMAKERS, AI ;

KLOPPENBORG, PW .

JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (06) :1971-1976

[8] Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency - A double-blind, placebo-controlled study [J].

Boger, RH ;

Skamira, C ;

BodeBoger, SM ;

Brabant, G ;

Muhlen, AVZ ;

Frolich, JC .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2706-2713

[9] Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency [J].

Borson-Chazot, F ;

Serusclat, A ;

Kalfallah, Y ;

Ducottet, X ;

Sassolas, G ;

Bernard, S ;

Labrousse, F ;

Pastene, J ;

Sassolas, A ;

Roux, Y ;

Berthezène, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1329-1333

[10] A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance [J].

Bülow, B ;

Erfurth, EM .

CLINICAL ENDOCRINOLOGY, 1999, 50 (01) :45-55

← 1 2 3 4 5 6 7 8 →